Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia

TY - JOUR

T1 - Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia

AU - Chyla, Brenda

AU - Daver, Naval

AU - Doyle, Kelly

AU - McKeegan, Evelyn

AU - Huang, Xin

AU - Ruvolo, Vivian

AU - Wang, Zixing

AU - Chen, Ken

AU - Souers, Andrew

AU - Leverson, Joel

AU - Potluri, Jalaja

AU - Boghaert, Erwin

AU - Bhathena, Anahita

AU - Konopleva, Marina

AU - Popovic, Relja

N1 - Funding Information: Vivian Ruvolo, Zixing Wang, and Ken Chen: nothing to disclose. Evelyn McKeegan was an employee of AbbVie, Inc. at the time of the study and may own stock. Marina Konopleva: consulted for and received research grants from AbbVie Inc. and Genentech. Naval Daver: received research grants from AbbVie Inc. and Genentech. Brenda Chyla, Kelly Doyle, Xin Huang, Andrew Souers, Joel Leverson, Jalaja Potluri, Erwin Boghaert, Anahita Bhathena, Relja Popovic: employees of AbbVie Inc. and may own stock.

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85051738042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051738042&partnerID=8YFLogxK

U2 - 10.1002/ajh.25146

DO - 10.1002/ajh.25146

M3 - Letter

C2 - 29770480

AN - SCOPUS:85051738042

SN - 0361-8609

VL - 93

SP - E202-E205

JO - American journal of hematology

JF - American journal of hematology

IS - 8

ER -